Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kierszenbaum

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cellsF Kierszenbaum, J J Wirth, P P McCann, et al.
Infection and Immunity|October 1, 1987
Impairment of macrophage function by inhibitors of ornithine decarboxylase activityF Kierszenbaum, J J Wirth, P P McCann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cellsF Kierszenbaum, W R Cuna, L A Beltz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1989
Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor componentsF Kierszenbaum, W R Cuna, L A Beltz, et al.
European Journal of Immunology|June 8, 1999
Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytesF Kierszenbaum, J L de Diego, M Fresno, et al.
Parasite Immunology|May 1, 1993
Alterations induced by Trypanosoma cruzi in activated mouse lymphocytesH M Lopez, M K Tanner, F Kierszenbaum, et al.
Parasite Immunology|April 1, 1995
Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytesF Kierszenbaum, H Mejia Lopez, M K Tanner, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1988
Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruziH A Molina, F Kierszenbaum, K J Hamann, et al.
Molecular and Biochemical Parasitology|May 9, 1998
The Trypanosoma cruzi immunosuppressive factor (TIF) targets a lymphocyte activation event subsequent to increased intracellular calcium ion concentration and translocation of protein kinase C but previous to cyclin D2 and cdk4 mRNA accumulationF Kierszenbaum, S Majumder, P Paredes, et al.
Molecular and Biochemical Parasitology|June 22, 1999
Knockout of the glutamate dehydrogenase gene in bloodstream Trypanosoma brucei in culture has no effect on editing of mitochondrial mRNAsA M Estévez, F Kierszenbaum, E Wirtz, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cellsF Kierszenbaum, J J Wirth, P P McCann, et al.
Infection and Immunity|October 1, 1987
Impairment of macrophage function by inhibitors of ornithine decarboxylase activityF Kierszenbaum, J J Wirth, P P McCann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cellsF Kierszenbaum, W R Cuna, L A Beltz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1989
Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor componentsF Kierszenbaum, W R Cuna, L A Beltz, et al.
European Journal of Immunology|June 8, 1999
Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytesF Kierszenbaum, J L de Diego, M Fresno, et al.
Parasite Immunology|May 1, 1993
Alterations induced by Trypanosoma cruzi in activated mouse lymphocytesH M Lopez, M K Tanner, F Kierszenbaum, et al.
Parasite Immunology|April 1, 1995
Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytesF Kierszenbaum, H Mejia Lopez, M K Tanner, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1988
Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruziH A Molina, F Kierszenbaum, K J Hamann, et al.
Molecular and Biochemical Parasitology|May 9, 1998
The Trypanosoma cruzi immunosuppressive factor (TIF) targets a lymphocyte activation event subsequent to increased intracellular calcium ion concentration and translocation of protein kinase C but previous to cyclin D2 and cdk4 mRNA accumulationF Kierszenbaum, S Majumder, P Paredes, et al.
Molecular and Biochemical Parasitology|June 22, 1999
Knockout of the glutamate dehydrogenase gene in bloodstream Trypanosoma brucei in culture has no effect on editing of mitochondrial mRNAsA M Estévez, F Kierszenbaum, E Wirtz, et al.
Pageof 13